NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells

Type 2 diabetes mellitus (T2DM) remains one of the most pressing health issues facing modern society. Several antidiabetic drugs are currently in clinical use to treat hyperglycaemia, but there is a need for new treatments that effectively restore pancreatic islet function in patients. Recent studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cyranka, Malgorzata, Monfeuga, Thomas, Vedovato, Natascia, Larabee, Chelsea M, Chandran, Anandhakumar, Toledo, Enrique M, de Wet, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091448/
https://www.ncbi.nlm.nih.gov/pubmed/35571112
http://dx.doi.org/10.3389/fphar.2022.861311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091448/
https://www.ncbi.nlm.nih.gov/pubmed/35571112
http://dx.doi.org/10.3389/fphar.2022.861311

Ejemplares similares